Dopamine neuron dysfunction and loss in the PrknR275W mouse model of Juvenile Parkinsonism
Maria RegoniiD, Letizia ZanettiiD, Martina Sevegnani, Chiara DomenicaleiD, Stefano MagnaboscoiD, Jyoti C. PateliD, Megan K. Fernandes, Ryan M. Feeley, Elena Monzani, Cecilia Mini, Stefano ComaiiD, Laura CherchiiD, Danilo De GregorioiD, Isabella Soliman, Fabio Ruto, Laura CrociiD, G. Giacomo ConsaleziD, Simona RodighieroiD, Andrea CiammolaiD, Flavia ValtortaiD, Michele MorariiD, Giovanni PiccoliiD, Margaret E. RiceiD, Jenny SassoneiD
Abstract
Mutations in the PRKN gene encoding the protein PARKIN cause Autosomal Recessive Juvenile Parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinsons disease (PD) mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. We created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. In PrknR275W mice, we analysed the anatomical and functional integrity of the nigrostriatal pathway, including striatal DA content and evoked striatal dopamine (DA) release, as well as the motor phenotype. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new PD model in which to study causative mechanisms of the disease, as well as test therapeutic strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 1.33
- Field percentile
- top 20%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival
Jongkyun Kang, Guodong Huang, … Jie Shen·eLifePeer-reviewed·Jun 10, 2024
- Parkin R274W mutation affects muscle physiology via the PARIS-PGC-1α pathway
M. Sevegnani, A. Lama, … G. Piccoli·bioRxiv·Oct 26, 2023
- Aging hastens locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression
Isabel Soto, Robert McManus, … Michael F. Salvatore·Experimental NeurologyPeer-reviewed·Jun 1, 2024
- Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology
Xin Yi Ng, Yumei Wu, … Mian Cao·npj Parkinson s DiseasePeer-reviewed·Feb 15, 2023
- Loss of PINK1 causes age-dependent mitochondrial trafficking deficits in nigrostriatal dopaminergic neurons through aberrant activation of p38 MAPK
Jingyu Zhao, Yuanxin Chen, … Chenjian Li·bioRxiv·Jul 17, 2024
- Upregulated extracellular matrix-related genes and impaired synaptic activity in dopaminergic and hippocampal neurons derived from Parkinson's disease patients with PINK1 and PARK2 mutations
Utkarsh Tripathi, Idan Rosh, … Shani Stern·bioRxiv·Dec 9, 2022